US 11434301
Anti-CD46 antibodies and methods of use
granted A61KA61K2039/505A61K2039/55
Quick answer
US patent 11434301 (Anti-CD46 antibodies and methods of use) held by The Regents of the University of California expires Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Sep 06 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 01 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61K, A61K2039/505, A61K2039/55, A61K47/68031, A61K47/6809